Adicet Bio, Inc. (ACET) › Cash & EquivalentsAdicet Bio, Inc. (ACET) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2016: $02017: $53.35M2018: $9.47M2019: $10.61M2020: $84.33M2021: $277.54M2022: $257.66M2023: $159.71M2024: $56.49M2025: $38.92M$38.92M2016Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$38.92M-31.1%2024$56.49M-64.6%2023$159.71M-38.0%2022$257.66M-7.2%2021$277.54M+229.1%2020$84.33M+695.0%2019$10.61M+11.9%2018$9.47M-82.2%2017$53.35M—2016$0—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share